Misplaced Pages

SCRM

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
#895104

10-573: SCRM may refer to: Scottish Centre for Regenerative Medicine Supply chain risk management Topics referred to by the same term [REDACTED] This disambiguation page lists articles associated with the title SCRM . If an internal link led you here, you may wish to change the link to point directly to the intended article. Retrieved from " https://en.wikipedia.org/w/index.php?title=SCRM&oldid=955876901 " Category : Disambiguation pages Hidden categories: Short description

20-894: A national role. The first meeting of the Scottish National Blood Transfusion Association (SNBTA) took place in Edinburgh in February 1940. In the 1940s Helen White played a key role in the development of the blood donor service in Edinburgh and throughout Scotland, on her initiative a network of voluntary organisers was established. The network was characterised by its friendliness and the care she took in making voluntary donation an enjoyable activity. There are five blood centres, in Aberdeen , Dundee , Edinburgh , Glasgow and Inverness . The SNBTS also has several mobile units that travel to

30-567: Is different from Wikidata All article disambiguation pages All disambiguation pages Scottish Centre for Regenerative Medicine The Centre for Regenerative Medicine (CRM) is a stem cell research centre at the University of Edinburgh in Scotland, dedicated to the study and development of new regenerative treatments for human diseases. The centre forms part of the university's Institute for Regeneration and Repair and

40-662: Is part of the BioQuarter cluster at Little France . The University of Edinburgh's history in stem cell research dates back to the early 1990s. Under the leadership of Austin Smith , the university's Centre for Genome Research became the first Institute of Stem Cell Research (ISCR) in the UK. The CRM was formed in 2008 as a merger of ISCR scientists with scientists from the University's College of Medicine and Veterinary Medicine , an initiative directed by Ian Wilmut . From 2008 to 2020,

50-527: Is the national blood , blood product and tissue provider. It makes up a Strategic Business Unit of NHS National Services Scotland (NSS). The first dedicated transfusion service in Scotland was formed at the Royal Infirmary of Edinburgh in the 1930s. The Edinburgh Blood Transfusion Service (EBTS) was established in 1936 with Jack Copland as Organiser and Helen White as Secretary. Helen White took over as Organiser in 1940 when Copland moved into

60-572: The CRM employs 300 scientists. Conditions being researched at the CRM include multiple sclerosis and heart and liver disease . On 25 August 2014, the centre grew the first working organ, a thymus , from scratch inside an animal. In 2019, the centre published the first in-human trial of a macrophage therapy for liver cirrhosis . The CRM building was officially opened by the Princess Royal on 28 May 2012. Designed by Sheppard Robson ,

70-697: The building is part of a total £600 million joint investment in stem cell biology and medicine by the Scottish Government and the University of Edinburgh. The CRM building is also home to applied scientists working with the Scottish National Blood Transfusion Service and Roslin Cells. It contains laboratory and support space, a company incubator unit, and a clinical translation unit which enables

80-488: The centre had MRC status. Charles ffrench-Constant became the 2nd Director of CRM in 2010; he was succeeded by Stuart Forbes in 2015. In 2024, Anna Williams and Tilo Kunath were appointed co-directors of the centre. As of 2016 , the CRM had attracted £55 million in research funding. The centre is home to 26 research groups; group leaders include Clare Blackburn , Ian Chambers, Charles ffrench-Constant , Stuart Forbes, Dónal O'Carroll and Ian Wilmut . As of 2019 ,

90-448: The production of cells at Good Manufacturing Practice (GMP) grade. CRM spinout companies include Cellinta (developing gene therapies for cancer) and Resolution Therapeutics (developing cell treatments for liver damage). 55°55′11″N 3°07′52″W  /  55.9198°N 3.131°W  / 55.9198; -3.131 Scottish National Blood Transfusion Service The Scottish National Blood Transfusion Service ( SNBTS )

100-497: The remote centres and communities. These are usually set up in village halls and community centres. They tend to return approximately every 13 weeks, which can allow for up to four donations each year. In November 2011 it was announced that a new national centre would be built within the Heriot-Watt research park in Edinburgh, and would include labs, offices and other facilities. By October 2014, construction work had begun on

#895104